Majestic Ideal Holdings LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
Ping An Biomedical Co., Ltd. reported a substantial increase in net loss and a significant decrease in revenue for the fiscal year ended September 30, 2025, primarily driven by higher credit losses and reduced customer demand.